カテゴリー： GlobalInfoResearch, 世界

NK細胞療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global NK Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9103754）・商品コード：GIR9103754
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月30日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、NK細胞療法の世界市場について調べ、まとめました。種類別セグメントは、NK細胞療法、NK細胞指向性抗体等、用途別セグメントは、がん、消化器疾患、その他等に区分しました。NK細胞療法の世界市場概観、企業動向、企業別NK細胞療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・NK細胞療法の市場概観
・NK細胞療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・NK細胞療法の企業別販売動向、市場シェア、市場集中度、競争動向
・NK細胞療法の世界市場規模
・NK細胞療法の北米市場分析（アメリカ、カナダ、メキシコ等）
・NK細胞療法のアメリカ市場規模推移
・NK細胞療法のカナダ市場規模推移
・NK細胞療法のメキシコ市場規模推移
・NK細胞療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・NK細胞療法のドイツ市場規模推移
・NK細胞療法のイギリス市場規模推移
・NK細胞療法のロシア市場規模推移
・NK細胞療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・NK細胞療法の日本市場規模推移
・NK細胞療法の中国市場規模推移
・NK細胞療法の韓国市場規模推移
・NK細胞療法のインド市場規模推移
・NK細胞療法の東南アジア市場規模推移
・NK細胞療法の南米市場分析（ブラジル、アルゼンチン等）
・NK細胞療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・NK細胞療法の種類別分析/販売量、売上、市場シェア（NK細胞療法、NK細胞指向性抗体）
・NK細胞療法の用途別分析/市場規模（がん、消化器疾患、その他）
・NK細胞療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・NK細胞療法の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Description

Scope of the Report:
The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of NK Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the NK Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the NK Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate Pharma SA
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem Therapeutics
Fate Therapeutics
NantWorks
Fortress Biotech

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
NK Cell Therapies
NK Cell Directed Antibodies

NK Cell agents took the largest market share segment, accounting for 82% and growing fastest

Market Segment by Applications, can be divided into
Cancer
Gastrointestinal Diseases
Others

Cancer was the most widely used area at 66%

【レポートの目次】

Table of Contents

1 NK Cell Therapy Market Overview
1.1 Product Overview and Scope of NK Cell Therapy
1.2 Classification of NK Cell Therapy by Types
1.2.1 Global NK Cell Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global NK Cell Therapy Revenue Market Share by Types in 2018
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global NK Cell Therapy Market by Application
1.3.1 Global NK Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Global NK Cell Therapy Market by Regions
1.4.1 Global NK Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) NK Cell Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) NK Cell Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NK Cell Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) NK Cell Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NK Cell Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of NK Cell Therapy (2014-2024)
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Business Overview
2.1.2 NK Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Kiadis Pharma
2.2.1 Business Overview
2.2.2 NK Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Chipscreen Biosciences
2.3.1 Business Overview
2.3.2 NK Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Innate Pharma SA
2.4.1 Business Overview
2.4.2 NK Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Dragonfly Therapeutics
2.5.1 Business Overview
2.5.2 NK Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Affimed
2.6.1 Business Overview
2.6.2 NK Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Nkarta Therapeutics
2.7.1 Business Overview
2.7.2 NK Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Glycostem Therapeutics
2.8.1 Business Overview
2.8.2 NK Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Fate Therapeutics
2.9.1 Business Overview
2.9.2 NK Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 NantWorks
2.10.1 Business Overview
2.10.2 NK Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Fortress Biotech
2.11.1 Business Overview
2.11.2 NK Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global NK Cell Therapy Market Competition, by Players
3.1 Global NK Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 NK Cell Therapy Players Market Share
3.2.2 Top 10 NK Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global NK Cell Therapy Market Size by Regions
4.1 Global NK Cell Therapy Revenue and Market Share by Regions
4.2 North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America NK Cell Therapy Revenue by Countries
5.1 North America NK Cell Therapy Revenue by Countries (2014-2019)
5.2 USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe NK Cell Therapy Revenue by Countries
6.1 Europe NK Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific NK Cell Therapy Revenue by Countries
7.1 Asia-Pacific NK Cell Therapy Revenue by Countries (2014-2019)
7.2 China NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America NK Cell Therapy Revenue by Countries
8.1 South America NK Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue NK Cell Therapy by Countries
9.1 Middle East and Africa NK Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global NK Cell Therapy Market Segment by Type
10.1 Global NK Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global NK Cell Therapy Market Forecast by Type (2019-2024)
10.3 NK Cell Therapies Revenue Growth Rate (2014-2024)
10.4 NK Cell Directed Antibodies Revenue Growth Rate (2014-2024)
11 Global NK Cell Therapy Market Segment by Application
11.1 Global NK Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 NK Cell Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2014-2019)
11.4 Gastrointestinal Diseases Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global NK Cell Therapy Market Size Forecast (2019-2024)
12.1 Global NK Cell Therapy Market Size Forecast (2019-2024)
12.2 Global NK Cell Therapy Market Forecast by Regions (2019-2024)
12.3 North America NK Cell Therapy Revenue Market Forecast (2019-2024)
12.4 Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
12.6 South America NK Cell Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure NK Cell Therapy Picture
Table Product Specifications of NK Cell Therapy
Table Global NK Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global NK Cell Therapy Revenue Market Share by Types in 2018
Figure NK Cell Therapies Picture
Figure NK Cell Directed Antibodies Picture
Table Global NK Cell Therapy Revenue (Million USD) by Application (2014-2024)
Figure NK Cell Therapy Revenue Market Share by Applications in 2018
Figure Cancer Picture
Figure Gastrointestinal Diseases Picture
Figure Others Picture
Table Global Market NK Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nektar Therapeutics NK Cell Therapy Type and Applications
Table Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kiadis Pharma Basic Information, Manufacturing Base and Competitors
Table Kiadis Pharma NK Cell Therapy Type and Applications
Table Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table Chipscreen Biosciences NK Cell Therapy Type and Applications
Table Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Innate Pharma SA Basic Information, Manufacturing Base and Competitors
Table Innate Pharma SA NK Cell Therapy Type and Applications
Table Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Dragonfly Therapeutics Basic Information, Manufacturing Base and Competitors
Table Dragonfly Therapeutics NK Cell Therapy Type and Applications
Table Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Affimed Basic Information, Manufacturing Base and Competitors
Table Affimed NK Cell Therapy Type and Applications
Table Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nkarta Therapeutics NK Cell Therapy Type and Applications
Table Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Glycostem Therapeutics Basic Information, Manufacturing Base and Competitors
Table Glycostem Therapeutics NK Cell Therapy Type and Applications
Table Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fate Therapeutics Basic Information, Manufacturing Base and Competitors
Table Fate Therapeutics NK Cell Therapy Type and Applications
Table Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NantWorks Basic Information, Manufacturing Base and Competitors
Table NantWorks NK Cell Therapy Type and Applications
Table NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fortress Biotech Basic Information, Manufacturing Base and Competitors
Table Fortress Biotech NK Cell Therapy Type and Applications
Table Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global NK Cell Therapy Revenue (Million USD) by Players (2014-2019)
Table Global NK Cell Therapy Revenue Share by Players (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Players in 2017
Figure Global NK Cell Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players NK Cell Therapy Revenue Market Share in 2018
Figure Global Top 10 Players NK Cell Therapy Revenue Market Share in 2018
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global NK Cell Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global NK Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global NK Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global NK Cell Therapy Revenue Market Share by Regions in 2018
Figure North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table North America NK Cell Therapy Revenue by Countries (2014-2019)
Table North America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America NK Cell Therapy Revenue Market Share by Countries in 2018
Figure USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Europe NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure France NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue Market Share by Countries in 2018
Figure China NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure India NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table South America NK Cell Therapy Revenue by Countries (2014-2019)
Table South America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Global NK Cell Therapy Revenue (Million USD) by Type (2014-2019)
Table Global NK Cell Therapy Revenue Share by Type (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Type (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Type in 2018
Table Global NK Cell Therapy Revenue Forecast by Type (2019-2024)
Figure Global NK Cell Therapy Market Share Forecast by Type (2019-2024)
Figure Global NK Cell Therapies Revenue Growth Rate (2014-2019)
Figure Global NK Cell Directed Antibodies Revenue Growth Rate (2014-2019)
Table Global NK Cell Therapy Revenue by Application (2014-2019)
Table Global NK Cell Therapy Revenue Share by Application (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Application (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Application in 2018
Table Global NK Cell Therapy Revenue Forecast by Application (2019-2024)
Figure Global NK Cell Therapy Market Share Forecast by Application (2019-2024)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Gastrointestinal Diseases Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global NK Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global NK Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure South America NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)


【掲載企業】

Nektar Therapeutics、 Kiadis Pharma、 Chipscreen Biosciences、 Innate Pharma SA、 Dragonfly Therapeutics、 Affimed、 Nkarta Therapeutics、 Glycostem Therapeutics、 Fate Therapeutics、 NantWorks、 Fortress Biotech、

★調査レポート[NK細胞療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9103754)販売に関する免責事項を必ずご確認ください。
★調査レポート[NK細胞療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 細胞療法プロセッシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102017 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、細胞療法プロセッシングの世界市場について調べ、まとめました。種類別セグメントは、製品、サービス、ソフトウェア等、用途別セグメントは、心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患等に区分しました。細胞療法プロセッシングの世界市場概観、企業動向、企業別細胞療法プロセッシングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・細胞療法プロセッシングの市場概観 ・細胞療法プロセッシングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・細胞療法プロセッシングの企業別販売動向、市場シェア、市場集中度、競争動向 ・細胞療法プロセッシングの世界市場規模 ・細胞療法プロセッシングの北米市場分析（アメリカ、カナダ、メキシコ等） ・細胞療法プロセッシングのアメリカ市場規模推移 ・細胞療法プロセッシングのカナダ市場規模推移 ・細胞療法プロセッシングのメキシコ市場規模推移 ・細胞療法プロセッシングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions. Scope of the Report: The global Cell therapy Processing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,...
  • 細胞治療器の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100014 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、細胞治療器の世界市場について調べ、まとめました。種類別セグメントは、ヒト細胞、動物細胞等、用途別セグメントは、細胞処理、細胞保存分布および取り扱い、プロセス監視および品質管理等に区分しました。細胞治療器の世界市場概観、メーカー動向、メーカー別細胞治療器シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・細胞治療器の市場概観 ・細胞治療器の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・細胞治療器の企業別販売動向、市場シェア、市場集中度、競争動向 ・細胞治療器の世界市場規模 ・細胞治療器の北米市場分析（アメリカ、カナダ、メキシコ等） ・細胞治療器のアメリカ市場規模推移 ・細胞治療器のカナダ市場規模推移 ・細胞治療器のメキシコ市場規模推移 ・細胞治療器のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Cell Therapy Instrument is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cell Therapy Instrument in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sartorius AG Stemcell Technologies Inc. Lonza Danaher (Beckman...
  • がん治療における感染制御の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101987 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、がん治療における感染制御の世界市場について調べ、まとめました。種類別セグメントは、放射線療法、免疫療法、伝統的な手術、幹細胞移植療法、化学療法、標的療法、光線力学療法、その他等、用途別セグメントは、病院、製薬会社、医療機器会社、その他等に区分しました。がん治療における感染制御の世界市場概観、企業動向、企業別がん治療における感染制御シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がん治療における感染制御の市場概観 ・がん治療における感染制御の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がん治療における感染制御の企業別販売動向、市場シェア、市場集中度、競争動向 ・がん治療における感染制御の世界市場規模 ・がん治療における感染制御の北米市場分析（アメリカ、カナダ、メキシコ等） ・がん治療における感染制御のアメリカ市場規模推移 ・がん治療における感染制御のカナダ市場規模推移 ・がん治療における感染制御のメキシコ市場規模推移 ・がん治療における感染制御のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The Preventing Infections in Cancer Patients campaign provides resources to help lower the risk of cancer patients developing potentially life-threatening infections during chemotherapy treatment. Scope of the Report: The global Infection Control in Cancer Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important...
  • 光線力学療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101278 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、光線力学療法の世界市場について調べ、まとめました。種類別セグメントは、レーザー治療器、光増感剤等、用途別セグメントは、腫瘍学、皮膚科、眼科等に区分しました。光線力学療法の世界市場概観、企業動向、企業別光線力学療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・光線力学療法の市場概観 ・光線力学療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・光線力学療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・光線力学療法の世界市場規模 ・光線力学療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・光線力学療法のアメリカ市場規模推移 ・光線力学療法のカナダ市場規模推移 ・光線力学療法のメキシコ市場規模推移 ・光線力学療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Photodynamic Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Photodynamic Therapy. Europe also play important roles in global market,...
  • 熱傷療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101447 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、熱傷療法の世界市場について調べ、まとめました。種類別セグメントは、医療、理学療法、外科、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。熱傷療法の世界市場概観、企業動向、企業別熱傷療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・熱傷療法の市場概観 ・熱傷療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・熱傷療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・熱傷療法の世界市場規模 ・熱傷療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・熱傷療法のアメリカ市場規模推移 ・熱傷療法のカナダ市場規模推移 ・熱傷療法のメキシコ市場規模推移 ・熱傷療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Treatment for burn. Scope of the Report: The global Burn Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Burn Therapy. Europe also play important roles in...
  • 電気刺激療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100415 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、電気刺激療法の世界市場について調べ、まとめました。種類別セグメントは、体外衝撃波療法、磁場療法、超音波療法、経皮的電気神経刺激（TENS）療法、その他等、用途別セグメントは、整形外科、心臓病学、泌尿器科、疼痛管理、急性および慢性浮腫、その他等に区分しました。電気刺激療法の世界市場概観、企業動向、企業別電気刺激療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・電気刺激療法の市場概観 ・電気刺激療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・電気刺激療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・電気刺激療法の世界市場規模 ・電気刺激療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・電気刺激療法のアメリカ市場規模推移 ・電気刺激療法のカナダ市場規模推移 ・電気刺激療法のメキシコ市場規模推移 ・電気刺激療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Electrical Stimulation Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Electrical Stimulation Therapy. Europe also play important roles in...

    • ◆H&Iグローバルリサーチのお客様（例）◆